Akero Therapeutics Stock Surges 19% After Novo Nordisk’s $5.2B Acquisition Deal
The Akero Therapeutics stock jumped sharply, up 19 %, following the announcement that Novo Nordisk will acquire the biotech company in a deal valued at up to $5.2 billion. This move in the stock market has drawn attention across the healthcare and biotech sectors, and it offers key lessons in stock research about how acquisition…